サマリー

アジア太平洋地域の泌尿器科用レーザー市場は、2022年の157,815.00千米ドルから2030年には232,730.64千米ドルに達し、2023年から2030年の予測期間中にCAGR 5.0％で成長すると予測されている。

市場細分化：
アジア太平洋地域の泌尿器科用レーザー市場：レーザータイプ別（ホルミウムイットリウムアルミニウムガーネット（Ho:Yag）、ツリウムイットリウムアルミニウムガーネット（Thu:Yag）、ネオジムドープイットリウムアルミニウムガーネット（Nd:Yag）、リン酸チタニルイットリウムアルミニウムガーネット（Ktp:Yag）、ダイオードレーザー、エルビウム：Yttrium Aluminum Garnet Laser, Lithium Borate, and Others), Modality (Portable, Standalone), Application (Urolithiasis, Benign Prostatic Hyperplasia (BPH), Partial Kidney Resection, Removal of Kidney Stones, Urethral Strictures, Tumors, and Others), End User (Hospitals, Urological Clinic、外来手術センター、その他）、流通チャネル（直接入札、小売販売、オンライン販売、その他）、国（日本、中国、オーストラリア、インド、韓国、シンガポール、インドネシア、タイ、マレーシア、フィリピン、その他アジア太平洋地域） - 産業動向と2030年までの予測

アジア太平洋地域の泌尿器科用レーザー市場ダイナミクスの概要：

促進要因

- レーザー機器の製品承認数の増加
抑制要因

- 泌尿器科疾患の治療に対する認識不足

機会

- レーザー技術の進歩

市場プレーヤー

アジア太平洋地域の泌尿器科用レーザー市場に参入している主な市場プレイヤーを以下に示す：

- ボストン・サイエンティフィック社またはその関連会社
- クック
- オリンパス株式会社
- コヒーレント社
- ドルニエ・メドテック
- リチャード・ウルフ社
- BD
- アレンジャー
- ギガレーザー
- EMS泌尿器科
- リマーレーザー社
- モノクローム
- アドビン泌尿器科
- ロカメド
- バイソンメディカル
- バイオリテックAG
- ポテントメディカル
- ヘルスウェア社
- ユニークメディカルデバイス

ページTOPに戻る

目次

TABLE OF CONTENTS
1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 OVERVIEW OF THE ASIA-PACIFIC UROLOGY LASER MARKET 16
1.4 CURRENCY AND PRICING 18
1.5 LIMITATIONS 18
1.6 MARKETS COVERED 18
2 MARKET SEGMENTATION 22
2.1 MARKETS COVERED 22
2.2 GEOGRAPHICAL SCOPE 23
2.3 YEARS CONSIDERED FOR THE STUDY 24
2.4 DBMR TRIPOD DATA VALIDATION MODEL 25
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 28
2.6 MULTIVARIATE MODELLING 29
2.7 PRODUCT TYPE LIFELINE CURVE 29
2.8 DBMR MARKET POSITION GRID 30
2.9 VENDOR SHARE ANALYSIS 32
2.10 MARKET END USER COVERAGE GRID 33
2.11 SECONDARY SOURCES 34
2.12 ASSUMPTIONS 34
3 EXECUTIVE SUMMARY 35
4 PREMIUM INSIGHT 37
4.1 PESTEL ANALYSIS 38
4.2 PORTER’S FIVE FORCES 39
4.3 IMPORT-EXPORT ANALYSIS 40
4.3.1 IMPORT 40
4.3.1.1 INDIA 40
4.3.2 EXPORT 40
4.4 STRATEGIC INITIATIVES 41
4.5 PRICING ANALYSIS 42
4.6 ADOPTION OF LASER 42
5 ASIA-PACIFIC UROLOGY LASER MARKET, EPIDEMIOLOGY 44
5.1 INCIDENCE AND PREVALENCE OF UROLOGY DISORDERS, BY COUNTRY 44
5.2 UROLITHIASIS 44
5.3 BENIGN PROSTATIC HYPERPLASIA (BPH) 45
5.4 PARTIAL KIDNEY RESECTION 47
5.5 KIDNEY STONES 47
5.6 URETHRAL STRICTURES 48
5.7 TUMORS 48
6 ASIA-PACIFIC UROLOGY LASER MARKET, REGULATIONS 49
6.1 REGULATORY SCENARIO IN THE U.S. 49
6.2 REGULATORY SCENARIO IN AUSTRALIA 49
6.3 REGULATORY SCENARIO IN INDIA 50
6.4 REGULATORY SCENARIO IN U.K. 51
7 MARKET OVERVIEW 52
7.1 DRIVERS 54
7.1.1 RISING NUMBER OF PATIENTS RELATED TO UROLOGY DISORDERS ASIA PACIFICLY 54
7.1.2 INCREASED INCLINATION TOWARDS NON-INVASIVE SURGERIES 54
7.1.3 RISE IN THE NUMBER OF PRODUCT APPROVAL FOR LASER DEVICES 54
7.1.4 RISING RESEARCH AND DEVELOPMENT ACTIVITIES FOR UROLOGY LASER DEVICES 55
7.2 RESTRAINTS 56
7.2.1 HIGH COST OF UROLOGY LASER DEVICE AND PROCEDURE 56
7.2.2 SAFETY CONCERNS AND ADVERSE EFFECTS ASSOCIATED WITH LASER PROCEDURES SAFETY CONCERNS 56
7.2.3 LACK OF AWARENESS ABOUT TREATMENT FOR UROLOGICAL CONDITIONS 56
7.3 OPPORTUNITIES 57
7.3.1 TECHNOLOGICAL ADVANCEMENTS IN LASER TECHNOLOGY 57
7.3.2 STRATEGIC INITIATIVES BY EMERGING PLAYERS 58
7.4 CHALLENGES 58
7.4.1 LACK OF SKILLED PROFESSIONALS 58
7.4.2 STRINGENT REGULATIONS 59
8 ASIA-PACIFIC UROLOGY LASER MARKET, BY LASER TYPE 60
8.1 OVERVIEW 61
8.2 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG) 64
8.3 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG) 64
8.4 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG) 65
8.5 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG) 65
8.6 DIODE LASER 66
8.7 ERBIUM: YTTRIUM ALUMINUM GARNET LASER 66
8.8 LITHIUM BORATE 67
8.9 OTHERS 67
9 ASIA-PACIFIC UROLOGY LASER MARKET, BY MODALITY 68
9.1 OVERVIEW 69
9.2 PORTABLE 72
9.3 STANDALONE 72
10 ASIA-PACIFIC UROLOGY LASER MARKET, BY APPLICATION 73
10.1 OVERVIEW 74
10.2 UROLITHIASIS 77
10.2.1 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG) 77
10.2.2 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG) 78
10.2.3 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG) 78
10.2.4 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG) 78
10.2.5 DIODE LASER 78
10.2.6 ERBIUM: YTTRIUM ALUMINUM GARNET LASER 78
10.2.7 LITHIUM BORATE 78
10.2.8 OTHERS 78
10.3 BENIGN PROSTATIC HYPERPLASIA (BPH) 78
10.3.1 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG) 79
10.3.2 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG) 79
10.3.3 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG) 80
10.3.4 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG) 80
10.3.5 DIODE LASER 80
10.3.6 ERBIUM: YTTRIUM ALUMINUM GARNET LASER 80
10.3.7 LITHIUM BORATE 80
10.3.8 OTHERS 80
10.4 PARTIAL KIDNEY RESECTION 80
10.4.1 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG) 81
10.4.2 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG) 81
10.4.3 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG) 81
10.4.4 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG) 81
10.4.5 DIODE LASER 81
10.4.6 ERBIUM: YTTRIUM ALUMINUM GARNET LASER 82
10.4.7 LITHIUM BORATE 82
10.4.8 OTHERS 82
10.5 REMOVAL OF KIDNEY STONES 82
10.5.1 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG) 83
10.5.2 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG) 83
10.5.3 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG) 83
10.5.4 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG) 83
10.5.5 DIODE LASER 83
10.5.6 ERBIUM: YTTRIUM ALUMINUM GARNET LASER 83
10.5.7 LITHIUM BORATE 84
10.5.8 OTHERS 84
10.6 URETHRAL STRICTURES 84
10.6.1 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG) 85
10.6.2 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG) 85
10.6.3 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG) 85
10.6.4 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG) 85
10.6.5 DIODE LASER 85
10.6.6 ERBIUM: YTTRIUM ALUMINUM GARNET LASER 85
10.6.7 LITHIUM BORATE 86
10.6.8 OTHERS 86
10.7 TUMORS 86
10.7.1 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG) 87
10.7.2 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG) 87
10.7.3 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG) 87
10.7.4 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG) 87
10.7.5 DIODE LASER 87
10.7.6 ERBIUM: YTTRIUM ALUMINUM GARNET LASER 87
10.7.7 LITHIUM BORATE 87
10.7.8 OTHERS 87
10.8 OTHERS 87
10.8.1 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG) 88
10.8.2 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG) 88
10.8.3 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG) 89
10.8.4 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG) 89
10.8.5 DIODE LASER 89
10.8.6 ERBIUM: YTTRIUM ALUMINUM GARNET LASER 89
10.8.7 LITHIUM BORATE 89
10.8.8 OTHERS 89
11 ASIA-PACIFIC UROLOGY LASER MARKET, BY END USER 90
11.1 OVERVIEW 91
11.2 HOSPITALS 94
11.3 UROLOGICAL CLINICS 94
11.4 AMBULATORY SURGICAL CENTERS 94
11.5 OTHERS 95
12 ASIA-PACIFIC UROLOGY LASER MARKET, BY DISTRIBUTION CHANNEL 96
12.1 OVERVIEW 97
12.2 DIRECT TENDER 100
12.3 RETAIL SALES 100
12.4 ONLINE SALES 100
12.5 OTHERS 101
13 ASIA-PACIFIC UROLOGY LASER MARKET, BY REGION 102
13.1 ASIA-PACIFIC 103
13.1.1 JAPAN 107
13.1.2 CHINA 107
13.1.3 SOUTH KOREA 107
13.1.4 INDIA 107
13.1.5 AUSTRALIA 107
13.1.6 SINGAPORE 107
13.1.7 THAILAND 107
13.1.8 INDONESIA 107
13.1.9 MALAYSIA 107
13.1.10 PHILIPPINES 107
13.1.11 REST OF ASIA-PACIFIC 107
14 ASIA-PACIFIC UROLOGY LASER MARKET, COMPANY LANDSCAPE 108
14.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 108
15 SWOT ANALYSIS 109
16 COMPANY PROFILE 110
16.1 BOSTON SCIENTIFIC CORPORATION 110
16.1.1 COMPANY SNAPSHOT 110
16.1.2 REVENUE ANALYSIS 110
16.1.3 COMPANY SHARE ANALYSIS 111
16.1.4 PRODUCT PORTFOLIO 111
16.1.5 RECENT DEVELOPMENT 111
16.2 COOK 113
16.2.1 COMPANY SNAPSHOT 113
16.2.2 COMPANY SHARE ANALYSIS 113
16.2.3 PRODUCT PORTFOLIO 114
16.2.4 RECENT DEVELOPMENT 114
16.3 OLYMPUS CORPORATION 115
16.3.1 COMPANY SNAPSHOT 115
16.3.2 REVENUE ANALYSIS 115
16.3.3 COMPANY SHARE ANALYSIS 116
16.3.4 PRODUCT PORTFOLIO 116
16.3.5 RECENT DEVELOPMENT 116
16.4 COHERENT, INC. 117
16.4.1 COMPANY SNAPSHOT 117
16.4.2 REVENUE ANALYSIS 117
16.4.3 COMPANY SHARE ANALYSIS 118
16.4.4 PRODUCT PORTFOLIO 118
16.4.5 RECENT DEVELOPMENT 118
16.5 DORNIER MEDTECH 119
16.5.1 COMPANY SNAPSHOT 119
16.5.2 COMPANY SHARE ANALYSIS 119
16.5.3 PRODUCT PORTFOLIO 120
16.5.4 RECENT DEVELOPMENT 120
16.6 ADVIN HEALTH CARE 121
16.6.1 COMPANY SNAPSHOT 121
16.6.2 PRODUCT PORTFOLIO 121
16.6.3 RECENT DEVELOPMENTS 121
16.7 ALLENGERS 122
16.7.1 COMPANY SNAPSHOT 122
16.7.2 PRODUCT PORTFOLIO 122
16.7.3 RECENT DEVELOPMENT 122
16.8 BD 123
16.8.1 COMPANY SNAPSHOT 123
16.8.2 REVENUE ANALYSIS 123
16.8.3 PRODUCT PORTFOLIO 124
16.8.4 RECENT DEVELOPMENTS 124
16.9 BIOLITEC AG 125
16.9.1 COMPANY SNAPSHOT 125
16.9.2 PRODUCT PORTFOLIO 125
16.9.3 RECENT DEVELOPMENT 125
16.10 BISON MEDICAL 126
16.10.1 COMPANY SNAPSHOT 126
16.10.2 PRODUCT PORTFOLIO 126
16.10.3 RECENT DEVELOPMENTS 126
16.11 CONVERGENT LASER TECHNOLOGIES 127
16.11.1 COMPANY SNAPSHOT 127
16.11.2 PRODUCT PORTFOLIO 127
16.11.3 RECENT DEVELOPMENTS 127
16.12 EMS UROLOGY 128
16.12.1 COMPANY SNAPSHOT 128
16.12.2 PRODUCT PORTFOLIO 128
16.12.3 RECENT DEVELOPMENTS 128
16.13 GIGAALASER 129
16.13.1 COMPANY SNAPSHOT 129
16.13.2 PRODUCT PORTFOLIO 129
16.13.3 RECENT DEVELOPMENTS 129
16.14 HEALTHWARE PVT LTD. 130
16.14.1 COMPANY SNAPSHOT 130
16.14.2 PRODUCT PORTFOLIO 130
16.14.3 RECENT DEVELOPMENT 130
16.15 HYPERPHOTONICS. 131
16.15.1 COMPANY SNAPSHOT 131
16.15.2 PRODUCT PORTFOLIO 131
16.15.3 RECENT DEVELOPMENT 131
16.16 INTERMEDIC ARFRAN 132
16.16.1 COMPANY SNAPSHOT 132
16.16.2 PRODUCT PORTFOLIO 132
16.16.3 RECENT DEVELOPMENT 132
16.17 LIMMER LASER GMBH 133
16.17.1 COMPANY SNAPSHOT 133
16.17.2 PRODUCT PORTFOLIO 133
16.17.3 RECENT DEVELOPMENTS 133
16.18 MONOCROM 134
16.18.1 COMPANY SNAPSHOT 134
16.18.2 PRODUCT PORTFOLIO 134
16.18.3 RECENT DEVELOPMENT 134